Why HIV Mutates So Rapidly: Reverse Transcriptase Errors and Clinical Consequences

HIV's extraordinary mutation rate stems from its replication enzyme, reverse transcriptase (RT), which converts viral RNA into DNA. Unlike cellular DNA polymerases, RT lacks a proofreading (3'→5' exonuclease) function, so errors (misincorporations, insertions, deletions) go uncorrected.

Consequences of High Mutation Rate

  • Immune evasion: Rapidly changing envelope glycoproteins (gp120/gp41) outpace antibody and CTL responses.
  • Tissue tropism adaptation: Mutations allow infection of diverse cell types (CD4+ T cells, macrophages, microglia, dendritic cells).
  • Drug resistance: Single-point mutations confer resistance to NRTIs, NNRTIs, PIs, INSTIs. Resistance emerges quickly with monotherapy or poor adherence.
  • Vaccine challenge: Global sequence diversity complicates immunogen design.

Clinical Implications

  • Combination antiretroviral therapy (cART) with ≥3 drugs from ≥2 classes suppresses replication below resistance threshold.
  • Resistance testing (genotypic/phenotypic) guides regimen selection.
  • Novel strategies: broadly neutralizing antibodies, capsid inhibitors, latency-reversing agents aim to stay ahead of viral evolution.

HIV's mutability is a formidable obstacle, but also drives innovation in antiviral development.

HIV & AIDS - Related Articles